An increased number of 53BP1 and χH2AX foci were visible even at the lowest dose rate, further demonstrating that rucaparib is a potent radiosensitizer for PCa cells that harbor a fusion gene (Fig. 7C). Here, H2AX is linked to posterior cortical atrophy.